Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

NCT01700985 ·Status: COMPLETED ·Phase: PHASE2

To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris

NCT00050661 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

NCT01828086 ·Status: COMPLETED ·Phase: PHASE1

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

NCT01640951 ·Status: COMPLETED ·Phase: PHASE3

A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

NCT02576678 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

NCT05478499 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290 ·Status: TERMINATED ·Phase: PHASE2

Apremilast in Palmo-Plantar Psoriasis

NCT02400749 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

NCT01225731 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00646191 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

NCT06846710 ·Status: RECRUITING ·Phase: PHASE1

Long-Term Follow-Up Study of Psoriasis Patients

NCT00131066 ·Status: COMPLETED

Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

NCT00111449 ·Status: COMPLETED ·Phase: PHASE3

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

NCT01806597 ·Status: COMPLETED ·Phase: PHASE3

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT05495568 ·Status: COMPLETED ·Phase: PHASE3

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

NCT00604682 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

NCT01010542 ·Status: TERMINATED ·Phase: PHASE1

Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients

NCT01539915 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

NCT00230529 ·Status: COMPLETED ·Phase: PHASE2

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

NCT01132612 ·Status: COMPLETED ·Phase: PHASE2

Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients

NCT02574091 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

NCT01988103 ·Status: COMPLETED ·Phase: PHASE2